Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women-Reference-Cited by-同舟云学术

Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women

Published:2023-05 Issue: Volume:Volume 15 Page:837-843
ISSN:1179-1411
Container-title:International Journal of Women's Health
language:en
Short-container-title:IJWH

Author:

Alhassan Samia,Elmugadam Abdelgadir^ORCID,Elfadil Ghada A,Abubaker Nuha,Elfaki Elyasa M^ORCID,Hamza Alneil,Abdalhabib Ezeldine K^ORCID,Karar Tarig

Publisher

Informa UK Limited

Subject

Maternity and Midwifery,Obstetrics and Gynecology,Oncology

Reference28 articles.

1. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

2. Polycystic Ovary Syndrome

3. Poly Cystic Ovarian Syndrome: An Updated Overview

4. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

5. Teede H, Misso M, Costello M, et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome. National Health and Medical Research Council (NHMRC); 2018:1–198.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Analysis of Effective Management Strategies for Primary Amenorrhea of Reproductive Age in Saudi Arabia;Life;2024-06-17

2. Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis;Fertility and Sterility;2024-06

3. Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy;European Journal of Medical Research;2023-10-09